{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:35:28Z","timestamp":1793298928488,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.euf.2026.04.017","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:38:39Z","timestamp":1784288319000},"page":"956-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["PI-RADS\u2013stratified MRI-based PSA Density for Predicting Adverse Pathology after Robotic-assisted Laparoscopic Radical Prostatectomy"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1109-6621","authenticated-orcid":false,"given":"Hangcheng","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braden","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Blachman-Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskirat","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ahdoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Gurram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Turkbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2026.04.017_b0005","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euf.2026.04.017_b0010","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(21)00348-X","article-title":"Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial","volume":"22","author":"Nordstr\u00f6m","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2026.04.017_b0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2026.04.017_b0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/1055-9965.EPI-22-1038","article-title":"Estimating the number of men living with metastatic prostate cancer in the United States","volume":"32","author":"Devasia","year":"2023","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.euf.2026.04.017_b0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1200\/JCO.1999.17.1.168","article-title":"Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer","volume":"17","author":"D'Amico","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2026.04.017_b0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN Guidelines\u00ae insights: prostate cancer, version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euf.2026.04.017_b0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000475302","article-title":"Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer","volume":"25","author":"Sershon","year":"1994","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.04.017_b0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41391-017-0024-7","article-title":"Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer","volume":"21","author":"Nordstr\u00f6m","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2026.04.017_b0045","doi-asserted-by":"crossref","unstructured":"Magheli A, Rais-Bahrami S, Trock BJ, et al. Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy. J Urol 2008;179:1780\u20134; discussion 1784.","DOI":"10.1016\/j.juro.2008.01.032"},{"key":"10.1016\/j.euf.2026.04.017_b0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41391-022-00549-y","article-title":"PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer","volume":"26","author":"Frisbie","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2026.04.017_b0055","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.urology.2022.09.007","article-title":"MRI vs transrectal ultrasound to estimate prostate volume and PSAD: impact on prostate cancer detection","volume":"171","author":"Choe","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.euf.2026.04.017_b0060","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/JU.0000000000004368","article-title":"Impact of discordance between magnetic resonance imaging and ultrasound volume measurements on prostate fusion biopsy outcomes","volume":"213","author":"Borde","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.04.017_b0065","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.juro.2017.03.130","article-title":"The value of PSA density in combination with PI-RADS\u2122 for the accuracy of prostate cancer prediction","volume":"198","author":"Distler","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.04.017_b0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.euf.2019.06.014","article-title":"Prostate imaging reporting and data System 3 category cases at multiparametric magnetic resonance for prostate cancer: a systematic review and meta-analysis","volume":"6","author":"Maggi","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2026.04.017_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.euo.2023.08.002","article-title":"Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis","volume":"7","author":"Wang","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2026.04.017_b0080","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/jmri.26025","article-title":"Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer","volume":"48","author":"Gaur","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.euf.2026.04.017_b0085","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-5347(17)37393-7","article-title":"Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer","volume":"147","author":"Benson","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.04.017_b0090","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000020167","article-title":"Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1\u2013T2 prostate cancer","volume":"37","author":"Ravery","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2026.04.017_b0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-5347(05)64841-0","article-title":"Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score","volume":"168","author":"Freedland","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.04.017_b0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0022-5347(17)32832-X","article-title":"Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications","volume":"152","author":"Shinohara","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.04.017_b0105","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s10147-014-0696-0","article-title":"Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy","volume":"20","author":"Koie","year":"2015","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.euf.2026.04.017_b0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/RCT.0b013e318296af5f","article-title":"Prostate volumetric assessment by magnetic resonance imaging and transrectal ultrasound: impact of variation in calculated prostate-specific antigen density on patient eligibility for active surveillance program","volume":"37","author":"Dianat","year":"2013","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.euf.2026.04.017_b0115","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.30233","article-title":"Frequency of biopsy and tumor grade before vs after introduction of prostate magnetic resonance imaging","volume":"6","author":"Robinson","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euf.2026.04.017_b0120","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00261-016-0975-5","article-title":"Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer","volume":"42","author":"Oberlin","year":"2016","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.euf.2026.04.017_b0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41391-024-00896-y","article-title":"Trends in pre-biopsy MRI usage for prostate cancer detection, 2007\u20132022","volume":"28","author":"Soerensen","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euf.2026.04.017_b0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bjr\/tqad027","article-title":"Risk stratification of prostate cancer with MRI and prostate-specific antigen density-based tool for personalized decision making","volume":"97","author":"Rajendran","year":"2024","journal-title":"Br J Radiol"},{"key":"10.1016\/j.euf.2026.04.017_b0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/JU.0000000000004480","article-title":"Prostate-specific antigen density to select magnetic resonance imaging-targeted vs combined biopsy for prostate cancer diagnosis: a secondary analysis of the trio study","volume":"213","author":"Ahdoot","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.04.017_b0140","doi-asserted-by":"crossref","first-page":"161.e9","DOI":"10.1016\/j.urolonc.2021.11.019","article-title":"Oncologic outcomes of organ-confined Gleason grade group 4\u20135 prostate cancer after radical prostatectomy","volume":"40","author":"Preisser","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2026.04.017_b0145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1464-410X.2006.06022.x","article-title":"Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy?","volume":"97","author":"Jones","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2026.04.017_b0150","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1007\/s00330-015-4077-5","article-title":"Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results","volume":"26","author":"Park","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euf.2026.04.017_b0155","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12885-024-12029-8","article-title":"Pretreatment prostate-specific antigen density as a predictor of biochemical recurrence in patients with prostate cancer: a meta-analysis","volume":"24","author":"Cui","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.euf.2026.04.017_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157313","article-title":"Preoperative multiparametric magnetic resonance imaging predicts biochemical recurrence in prostate cancer after radical prostatectomy","volume":"11","author":"Ho","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2026.04.017_b0165","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-025-12272-y","article-title":"The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making","author":"Durmaz","year":"2026","journal-title":"Eur Radiol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:58:09Z","timestamp":1793296689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456926000684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2405456926000684"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2026.04.017","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PI-RADS\u2013stratified MRI-based PSA Density for Predicting Adverse Pathology after Robotic-assisted Laparoscopic Radical Prostatectomy","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2026.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}